<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anabolic and related sports supplements</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anabolic and related sports supplements</h1>
<div class="graphic"><div class="figure"><div class="ttl">Anabolic and related sports supplements</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Agent</td> <td class="subtitle1">Alternative name(s) listed on supplement label</td> <td class="subtitle1">Proposed mechanism of activity</td> <td class="subtitle1">Potential adverse effects</td> </tr> <tr> <td>Anabolic steroids</td> <td>Often described using chemical terms such as "androstra-3,5-diene-7,17-idone"</td> <td>Agonists of endogenous androgens, including testosterone</td> <td> <p>Acne vulgaris, gynecomastia, neuropsychiatric symptoms (mood disorders, aggressive <span class="nowrap_whitespace">behavior)<sup>[1-3]</sup></span></p> <p>With oral 17-alpha-alkylated androgens: LFT abnormalities, cholestatic jaundice, and peliosis <span class="nowrap_whitespace">hepatis<sup>[1-3]</sup></span></p> Hypogonadism (in males) can occur following <span class="nowrap_whitespace">discontinuation<sup>[2]</sup></span></td> </tr> <tr> <td>Aromatase inhibitors</td> <td>Testolactone, letrozole, anastrozole, exemestane</td> <td>Inhibits aromatase (which converts androstenedione to estrone, and testosterone to estradiol)</td> <td>Reduced bone mineral density, cardiovascular disease, diabetes, hypercholesterolemia, myalgias</td> </tr> <tr> <td>SARMs</td> <td>Andarine (GTX-007, <span class="nowrap_whitespace">S-<sub>4</sub></span> cpd), ostarinestarine, LGD-4033</td> <td>SARMs which bind better to androgen receptors in certain tissues (eg, muscle and bone) than to those in genital <span class="nowrap_whitespace">tissues<sup>[4,5]</sup></span></td> <td>Hallucinations, cholestasis, peliosis hepatis, hepatocellular injury</td> </tr> <tr> <td>SERMs (eg, tamoxifen, raloxifene, others)</td> <td>Typically not declared/listed on supplement label</td> <td>When used by males taking exogenous testosterone, they prevent gynecomastia that develops due to testosterone conversion to estradiol</td> <td>Flushing, hypertension, depression, menstrual irregularities</td> </tr> <tr> <td>IGF-1</td> <td>Deer antler velvet, deer velvet (deer antler velvet supplements have been adulterated with pharmaceutical IGF-1 <span class="nowrap_whitespace">[mecasermin])<sup>[6]</sup></span></td> <td>Stimulates growth of many tissues</td> <td>Irreversible enlargement of tissues, including joints, heart, and <span class="nowrap_whitespace">liver<sup>[6,7]</sup></span></td> </tr> </tbody></table></div><div class="graphic_lgnd">Testing of dietary supplements often reveals drugs not declared on labeling, labeled drugs/herbs not detected in the product, inaccurate quantities, and adulteration with prescription and experimental drugs. In addition, doses contained in supplements may far exceed pharmaceutical quantities, increasing the risks of adverse effects. For review of health risks and an approach to patient counseling, refer to UpToDate topic reviews of high-risk dietary supplements and performance-enhancing drugs and hormones in sport.</div><div class="graphic_footnotes">IGF-1: insulin-like growth factor 1; LFT: liver function test; SARMs: selective androgen receptor modulators; SERMs: selective estrogen receptor modulator.</div><div class="graphic_reference">References:
<ol>
<li>Timcheh-Hariri A, Balali-Mood M, Aryan E, et al. Toxic hepatitis in a group of 20 male body-builders taking dietary supplements. Food Chem Toxicol 2012; 50:3826.</li>
<li>Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett 2005; 158:167.</li>
<li>Krishnan PV, Feng ZZ, Gordon SC. Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements. J Clin Gastroenterol 2009; 43:672.</li>
<li>Van Wagoner RM, Eichner A, Bhasin S, et al. Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet. JAMA 2017; 318:2004.<br/></li>
<li>Cox HD, Eichner D. Detection of human insulin-like growth factor-1 in deer antler velvet supplements. Rapid Commun Mass Spectrom 2013; 27:2170.</li>
<li>Adams GR. Insulin-like growth factor in muscle growth and its potential abuse by athletes. Br J Sports Med 2000; 34:412.</li>
</ol></div><div id="graphicVersion">Graphic 139138 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
